Showing results (771-780 of 1,163) with videos related to

Sort By:
Pageof 117
JACC. Heart Failure|October 10, 2024
Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF TrialsHenri Lu, Brian L Claggett, Milton Packer, et al.
European Journal of Heart Failure|July 20, 2023
Rationale and design of ENDEAVOR: A sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fractionLars H Lund, Carolyn S P Lam, Patricia E Pizzato, et al.
Atherosclerosis|July 9, 2026
Global prevalence of elevated high-sensitivity C-reactive protein in patients with atherosclerotic cardiovascular disease, with and without chronic kidney disease: findings from the POSEIDON studyAnn Marie Navar, Ling Bai, Jesper Falkesgaard Højen, et al.
Heart, Lung & Circulation|March 4, 2016
Association of Age, Sex, Body Size and Ethnicity with Electrocardiographic Values in Community-based Older Asian AdultsEugene S J Tan, Jonathan Yap, Chang Fen Xu, et al.
Journal of the American College of Cardiology|August 2, 2023
Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3Stephen J Greene, Johann Bauersachs, Jasper J Brugts, et al.
Circulation|August 25, 2021
Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA)Justin A Ezekowitz, Yinggan Zheng, Alain Cohen-Solal, et al.
ESC Heart Failure|January 19, 2018
Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF)Tee Joo Yeo, Poh Shuan Daniel Yeo, Farid Abdul Hadi, et al.
European Journal of Heart Failure|March 30, 2023
Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: The VICTORIA echocardiographic substudyBurkert Pieske, Elisabeth Pieske-Kraigher, Carolyn S P Lam, et al.
Lancet (London, England)|August 30, 2022
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trialsMuthiah Vaduganathan, Kieran F Docherty, Brian L Claggett, et al.
Kidney International Reports|September 12, 2022
Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of UtilityGlen James, Juan Jose Garcia Sanchez, Juan Jesus Carrero, et al.
Pageof 117